Page last updated: 2024-11-05

hexahydrophthalic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Hexahydrophthalic acid, also known as 1,2-cyclohexanedicarboxylic acid, is a white crystalline solid. It is a key intermediate in the production of various polymers and resins, including polyesters, alkyd resins, and unsaturated polyester resins. These resins are used in a wide range of applications, such as coatings, adhesives, and fiberglass-reinforced plastics. Hexahydrophthalic acid can be synthesized through the hydrogenation of phthalic anhydride, a process that involves reacting phthalic anhydride with hydrogen gas in the presence of a suitable catalyst. The hydrogenation reaction typically occurs under high pressure and temperature. Hexahydrophthalic acid is studied extensively due to its versatile applications in polymer chemistry. Its unique chemical structure and properties make it an ideal building block for various polymers. Researchers are constantly exploring new ways to utilize hexahydrophthalic acid in the development of novel materials with enhanced performance characteristics. In terms of effects, hexahydrophthalic acid is generally considered to be safe for industrial use. However, as with any chemical, it is important to handle it with appropriate precautions. It is also important to note that the specific effects of hexahydrophthalic acid may vary depending on the concentration and exposure route. '

hexahydrophthalic acid: a major metabolite of hexahydrophthalic anhydride [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID15522
SCHEMBL ID20680
MeSH IDM0201957

Synonyms (41)

Synonym
1,2-benzenedicarboxylic acid, hexahydro-
nsc 239117
einecs 216-872-2
LS-13457
nsc 57637
1,2-cyclohexanedicarboxylic acid, cis-
nsc31593
nsc-31593
hexahydrophthalic acid
phthalic acid, hexahydro-
nsc-239117
1687-30-5
1,2-cyclohexanedicarboxylic acid
hexahydroorthophthalic acid
nsc239117
nsc-156209
nsc156209
cyclohexane-1,2-dicarboxylic acid
AKOS000274281
FT-0639852
FT-0660471
1,2-cyclohexanedicarboxylicacid
FT-0604952
FT-0633770
FT-0605371
F3095-4314
1,2-cyclohexanedicarboxylicacid, (1r,2r)-rel-
AKOS016040324
SCHEMBL20680
SY033780
DTXSID60875751
2-(4-methoxy-phenyl)-5-phenyl-2h-pyrazole-3-carboxylicacid
hexahydrophthalic acid; nsc 239117
methyl3-(cyclopentyloxy)-4-methoxybenzoate
BCP34409
mfcd00065321
A858315
BAA68730
cyclohexane-1,2-dicarboxylicacid
CS-0020077
EN300-24919

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" We collected 24-h urine samples before dosing (to be used as controls) and 24-h and 48-h after dosing, and serum at necropsy after 48 h."( Identification of potential biomarkers of exposure to di(isononyl)cyclohexane-1,2-dicarboxylate (DINCH), an alternative for phthalate plasticizers.
Calafat, AM; Furr, J; Gray, LE; Preau, JL; Samandar, E; Silva, MJ,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (30.00)18.2507
2000's3 (15.00)29.6817
2010's10 (50.00)24.3611
2020's1 (5.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.87 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.79 (4.65)
Search Engine Demand Index46.75 (26.88)
Search Engine Supply Index1.95 (0.95)

This Compound (36.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.35%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (95.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]